Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Vaxcyte, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $81.3 Billion
- Q2 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 29,272 shares of PCVX stock, worth $3.09 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,272
Previous 62
47112.9%
Holding current value
$3.09 Million
Previous $4,000
55150.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PCVX
# of Institutions
290Shares Held
110MCall Options Held
248KPut Options Held
109K-
Black Rock Inc. New York, NY9.94MShares$1.05 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.8MShares$1.03 Billion0.01% of portfolio
-
Janus Henderson Group PLC London, X08.87MShares$936 Million0.37% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.2MShares$866 Million9.34% of portfolio
-
Wellington Management Group LLP Boston, MA4.59MShares$485 Million0.06% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $6.26B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...